Assessment of visual contrast sensitivity in biotoxin-exposed individuals using four testing methods
Abstract
Background Environmental biotoxins, such as mould, are linked to neurological and visual dysfunction, including impaired visual contrast sensitivity (VCS). Testing VCS alterations is recommended as a biomarker for biotoxicity. This study compared four VCS tests in detecting VCS deficits in individuals with clinical signs of biotoxicity.Methods VCS was measured in 28 biotoxin-exposed individuals and 30 controls using four VCS tests: Shoemaker handheld chart, Online Contrast Sensitivity Test (OCSTTM), Clinic CSF App, and an Experimental VCS test. Neurotoxicity symptoms were assessed with the modified Q16 questionnaire, and pupil size was measured under standard lighting.Results Biotoxin-exposed participants had smaller pupil diameters (mean difference: 0.703 mm, p < 0.0001) and higher neurotoxicity scores (45.50 ± 13.0 vs. 22.00 ± 7.7). Contrast sensitivity was significantly reduced in exposed participants on digital VCS tests only. The Experimental VCS test demonstrated the highest diagnostic performance (100% sensitivity; 60–80% specificity), followed by OCSTTM and the Clinic CSF App. The Shoemaker handheld chart did not distinguish between groups.Conclusion These results highlight the effectiveness of digital VCS testing and symptom questionnaires as practical tools for detecting visual and neurological impairments in individuals with suspected biotoxin exposure
References (5)
- Chronic biotoxin-associated illness: Multiple-system symptoms, a vision deficit, and effective treatmentNeurotoxicology and Teratology · 2005
- Apartment residents' and day care workers' exposures to tetrachloroethylene and deficits in visual contrast sensitivity.Environmental Health Perspectives · 2002
- Possible estuary-associated syndrome: symptoms, vision, and treatment.Environmental Health Perspectives · 2001
- Mold and Mycotoxin Exposure and Brain DisordersJournal of Integrative Neuroscience · 2023
- Chronic inflammatory response syndrome: a review of the evidence of clinical efficacy of treatmentAnnals of Medicine and Surgery · 2024
Related Papers
- The Evolution of Chronic Inflammatory Response Syndrome (CIRS) and the Biotoxin Pathway2023 · 4 shared tags
- Phytoplankton Toxins and Their Potential Therapeutic Applications: A Journey toward the Quest for Potent PharmaceuticalsMarine Drugs · 2022 · 3 shared tags
- Introduction to Chronic Inflammatory Response Syndrome (CIRS)2023 · 3 shared tags
- Case Report: Low pressure hyperbaric oxygen therapy as a potential alternative treatment for chronic inflammatory response syndrome: a case study with notable improvements in fatigue, cognition, and testingFrontiers in Immunology · 2025 · 3 shared tags
- TUBB1, TUBA4A and MAPK as Indicators of Die-Back Degenerative Central Nervous System Disease in Patients Sickened by Specific Exposure to the Interior Environment of Water- Damaged BuildingsMedical Research Archives · 2023 · 3 shared tags
- Dampness and mould in Chinese homes and sick building syndrome (SBS) symptoms – Associations with climate, family size, cleaning and ventilation